Health
5 Things to Watch for in the Medicare Trustees’ Report
Medicare Sustainability
5 Things to Watch for in the Medicare Trustees’ Report
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
More Research is Essential to Improve Care for Dual-Eligible Beneficiaries
Complex Care
More Research is Essential to Improve Care for Dual-Eligible Beneficiaries
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
Commercial Sector Prices
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
Video Series: Health Care Prices
As Government Eyes Health Equity, Improving Care for Dual-Eligible Individuals Must Be a Key Focus
Complex Care
As Government Eyes Health Equity, Improving Care for Dual-Eligible Individuals Must Be a Key Focus
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
'We Have a Problem': New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market
Drug Prices
‘We Have a Problem’: New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Commercial Sector Prices
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Part 1: Fulfilling the Promises of the Surprise Billing Ban
Commercial Sector Prices
Part 1: Fulfilling the Promises of the Surprise Billing Ban
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Drug Prices
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Q&A
Complex Care
More Robust Data, Measurement Systems are Needed to Understand Impacts of Flexible Benefits in Medicare Program
In Wake of COVID-19, CMS Should Take Steps to Improve Care for People with Complex Needs
Complex Care
In Wake of COVID-19, CMS Should Take Steps to Improve Care for People with Complex Needs
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
COVID-19 Vaccines are Evidence that Government Intervention Works
Drug Prices
COVID-19 Vaccines are Evidence that Government Intervention Works
Op-Ed
The American Rescue Plan Seeks to Curb Overdose Deaths
The Opioid Epidemic
The American Rescue Plan Seeks to Curb Overdose Deaths
New Federal Funding Allows States to Rethink Long-Term Care
Complex Care
New Federal Funding Allows States to Rethink Long-Term Care
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
Commercial Sector Prices
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
When it Comes to Medicare-Medicaid Integration, States Have the Ball. Can They Make the Shot?
Complex Care
When it Comes to Medicare-Medicaid Integration, States Have the Ball. Can They Make the Shot?
The Opioid Epidemic
Richard Frank: COVID Dollars, Best Practices Arm Communities with New Weapons Against Drug-Overdose Scourge
Op-Ed
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.